Cynapsus Therapeutics
Toronto
About Cynapsus Therapeutics
Cynapsus is a pharmaceutical company that focuses on developing a non-injectable drug for Parkinson’s disease. The company specializes in the fields of healthcare, biotechnology, pharmaceutical, and therapeutics. It was founded in 2004 and headquartered in Toronto, Ontario.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $56.7M
- Funding stage: M&A
- Last round: Series Unknown (Mar 2015)
- Ticker: cve:CTH
- Website: cynapsus.ca
- Phone: 416-703-2449
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cynapsus-therapeutics-2138363 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.